RJFSA
BBP icon

Raymond James Financial Services Advisors’s Virtus Biotech ETF BBP Stock Holding History

Raymond James Financial Services Advisors’s Portfolio BBP Stock Details BBP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$489K Sell
7,777
-3,819
-33% -$238K ﹤0.01% 2639
2024
Q2 		$682K Buy
11,596
+3,013
+35% +$168K ﹤0.01% 2323
2024
Q1 		$486K Buy
+8,583
New +$500K ﹤0.01% 2539

Other funds holding BBP

CAMG
CWA Asset Management Group Naples, Florida $3.28B AUM 34.07% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
IFG
Independent Financial Group San Diego, California $5.35B AUM 43.78% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
JCM
Jag Capital Management St Louis, Missouri $1.07B AUM 60.59% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
Carson Wealth (CWM LLC)
Carson Wealth (CWM LLC) Omaha, Nebraska $38.1B AUM 19.66% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Raymond James Financial Services Advisors's BBP Position: Q3 2024 in Review

Raymond James Financial Services Advisors reduced its Virtus Biotech ETF (BBP) stake by 33% in Q3 2024, selling an estimated $238K and leaving 7,777 shares worth $489K. The position accounts for ﹤0.01% of the portfolio, ranked #2639.

Raymond James Financial Services Advisors first reported a position in BBP in Q1 2024 and has held it in 3 quarters since. The position peaked at $682K in Q2 2024. 14 funds tracked by Wall St. Rank hold BBP as of Q3 2024.

  • Raymond James Financial Services Advisors held 7,777 shares of Virtus Biotech ETF worth $489K as of Q3 2024.
  • Raymond James Financial Services Advisors sold 3,819 Virtus Biotech ETF shares in Q3 2024, an estimated $238K.
  • Virtus Biotech ETF made up ﹤0.01% of Raymond James Financial Services Advisors's portfolio in Q3 2024, its #2639 holding.
  • Raymond James Financial Services Advisors first reported a position in Virtus Biotech ETF in Q1 2024 and has held it in 3 quarters since.
  • Raymond James Financial Services Advisors's Virtus Biotech ETF position peaked at $682K in Q2 2024.
  • 14 funds tracked by Wall St. Rank held Virtus Biotech ETF as of Q3 2024.

Based on Raymond James Financial Services Advisors's 13F filing for Q3 2024, filed 18 Oct 2024.